Long-term, prolonged-release oral tapentadol for the treatment of refractory chronic low back pain: a single-center, observational study.
CONCLUSIONS: These results show the long-term effectiveness, safety and tolerability of oral tapentadol PR for the treatment of refractory chronic low back pain in a real-life clinical setting.
PMID: 29947490 [PubMed - in process]
Source: Pain Physician - Category: Anesthesiology Authors: Finco G, Mura P, Musu M, Deidda C, Saba M, Demelas I, Evangelista M, Sardo S Tags: Minerva Med Source Type: research
More News: Anesthesiology | Back Pain | Chronic Pain | Disability | Italy Health | Low Back Pain | Pain | Palliative | Palliative Care | Study